• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Tempus AI, Inc. - Class A Common Stock (NQ:TEM)

72.69 +6.04 (+9.06%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 21, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Tempus AI, Inc. - Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
News headline image
AI Found an Influenza Target That Survives Viral Mutation
August 10, 2026
Issued on behalf of MindWalk Holdings Corp. (Nasdaq: HYFT) 
From Equity Insider
Via GlobeNewswire
News headline image
Tempus Study Published in Nature Medicine Demonstrates Best-in-Class Performance of PRISM2 Across Diagnostic and Prognostic Applications
August 04, 2026
From Tempus AI, Inc.
Via Business Wire
News headline image
Tempus Reports Second Quarter 2026 Results
July 30, 2026
From Tempus AI, Inc.
Via Business Wire
News headline image
Tempus Announces National Launch of OneOme Pharmacogenomics Testing, Advancing Patient Safety and Precision Medicine
July 22, 2026
From Tempus AI, Inc
Via Business Wire
News headline image
Tempus Highlights Landmark Publication Demonstrating Safe, Real-World Deployment of Paige Prostate AI Suite in the UK National Health Service
July 16, 2026
From Tempus
Via Business Wire
News headline image
Tempus to Report Second Quarter 2026 Financial Results on July 30
July 09, 2026
From Tempus AI, Inc.
Via Business Wire
News headline image
Tempus Announces Research Collaboration with Angiosarcoma Awareness, Inc. to Uncover Insights on Rare Cancers
June 25, 2026
From Tempus AI, Inc.
Via Business Wire
News headline image
Tempus Announces Multi-Center Validation of AI-Enabled ECG Model for Predicting Atrial Fibrillation Risk Published in Heart Rhythm
June 11, 2026
From Tempus AI, Inc.
Via Business Wire
News headline image
Genetics in Medicine Open Study Demonstrates How Ambry Genetics’ ExomeReveal® RNA Testing Can Improve Diagnostic Clarity in Exome Testing
June 09, 2026
From Ambry Genetics
Via Business Wire
News headline image
Tempus to Present at the Goldman Sachs 47th Annual Global Healthcare Conference
June 05, 2026
From Tempus AI, Inc.
Via Business Wire
News headline image
Tempus Launches Open-Source Digital Pathology Consortium, Names Yale New Haven Health and Leading Cancer Center as Founding Members
June 03, 2026
From Tempus AI, Inc.
Via Business Wire
News headline image
Tempus Announces the Upcoming Clinical Availability of Its First Whole-Genome Sequencing Assay, xH
June 01, 2026
From Tempus AI, Inc.
Via Business Wire
News headline image
Tempus Unveils the Next-Generation of Lens, Expanding its Agentic AI Platform for Oncology Drug Development
May 31, 2026
From Tempus AI, Inc.
Via Business Wire
News headline image
Tempus Launches the PRECISION Challenge, a National Program Opening Its Foundation Model Work to the Broader Research Community
May 30, 2026
From Tempus AI, Inc.
Via Business Wire
News headline image
Tempus Introduces ‘Preview’: Bridging the Critical Time Gap Between Diagnostic Order and Definitive Results
May 30, 2026
From Tempus AI, Inc.
Via Business Wire
News headline image
Tempus Announces Initial Results from its Multimodal Foundation Model Efforts for Novel and Scalable Insight Generation in Oncology
May 29, 2026
From Tempus AI, Inc.
Via Business Wire
News headline image
Tempus Receives FDA Approval for Tumor Only xT CDx, Enabling Migration of its Entire DNA Solid Tumor Portfolio
May 29, 2026
From Tempus AI, Inc.
Via Business Wire
News headline image
Tempus Expands Next Platform to Deliver Real-Time Clinical Intelligence and Close Critical Care Gaps Across Oncology
May 28, 2026
From Tempus AI, Inc.
Via Business Wire
News headline image
Tempus Upgrades Its Smart Physician Platform, Hub, with Next-Generation Agentic AI Architecture to Streamline Clinical Workflows
May 27, 2026
From Tempus AI, Inc.
Via Business Wire
News headline image
Tempus Announces 37 Abstracts Accepted for Presentation at the 2026 American Society of Clinical Oncology Annual Meeting
May 26, 2026
From Tempus AI, Inc.
Via Business Wire
News headline image
Tempus Launches ArteraAI Prostate Test for Metastatic Patients, Marking the First Prostate Digital Pathology Algorithm in the Tempus Ecosystem Available for Clinical Use
May 21, 2026
From Tempus AI, Inc.
Via Business Wire
News headline image
Tempus Expands Strategic Collaboration with Bristol Myers Squibb to Enhance the Probability of Success Across Clinical Development Programs In Oncology and Neuroscience
May 14, 2026
From Tempus AI, Inc.
Via Business Wire
TechMediaBreaks – MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF) Advances AI Voice-Based Intoxication Detection as Real-Time Diagnostics Market Expands
May 11, 2026
Via Investor Brand Network
Topics Artificial Intelligence
The Future of Intoxication Detection May Be in Your Voice
May 11, 2026
Via Investor Brand Network
Topics Artificial Intelligence
News headline image
Ambry Genetics’ CARE Program® Wins 2026 MedTech Breakthrough Award for “Best Overall Health Informatics Solution”
May 11, 2026
From Ambry Genetics
Via Business Wire
News headline image
The Future of Intoxication Detection May Be in Your Voice
May 11, 2026
From BioMedWire
Via GlobeNewswire
News headline image
Tempus Announces Pricing of Upsized Offering of $400.0 Million of Convertible Senior Notes
May 08, 2026
From Tempus AI, Inc.
Via Business Wire
News headline image
Tempus AI, Inc. Announces Proposed Convertible Senior Notes Offering to Optimize Capital Structure and Reduce Interest Expense
May 07, 2026
From Tempus AI, Inc.
Via Business Wire
News headline image
Tempus Reports First Quarter 2026 Results
May 05, 2026
From Tempus AI, Inc.
Via Business Wire
News headline image
Tempus to Host Inaugural Investor Day on May 29, 2026
April 29, 2026
From Tempus AI, Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap